SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Instruments Regulatory News (OXIG)

Share Price Information for Oxford Instruments (OXIG)

Share Price is delayed by 15 minutes
Get Live Data
2,878.00    130.00 (4.73%)
Bid:
2,846.00
Ask:
2,862.00
Spread: 16.00 (0.562%)
Market Cap: £1.59b
OXIG Live PriceLast checked at - London Stock Exchange

Intraday Oxford Instruments Share Chart

Half Year Trading Update

16 Oct 2024 07:00

RNS Number : 3121I
Oxford Instruments PLC
16 October 2024
Β 

Β 

Oxford Instruments plc

Half-year trading update - 16 October 2024

Β 

Β 

Robust demand and order intake growthFull year trading in line with constant currency expectations

Β 

Oxford Instruments plc, a global provider of high technology products and services to many of the world's leading companies and scientific research communities, is today issuing a trading update for the half year ended 30 September 2024.

Β 

At constant currency, we expect to deliver circa 10% revenue growth for the first half, supported by order intake circa 3% ahead of the prior year. Adjusted operating profit will be slightly above last year. Group margin will be lower than last year, as expected, reflecting the mix effect of stronger revenue growth from Advanced Technologies.

Β 

On a reported basis, the currency headwind will result in adjusted operating profit and margin below the comparable period last year.

Β 

Imaging & Analysis

We have continued to see good growth in the first half of this financial year, with strong demand across our materials analysis and semiconductor markets. This more than offset softer demand from our healthcare & life science market. The division recorded a positive book-to-bill in the half year.

Β 

Advanced Technologies

Our compound semiconductor business continues to perform well, with strong revenue growth in the first half. In the quantum market, we have begun deliveries of an ongoing series of orders to a key customer, supporting good progress towards a return to profitability. The division continues to have good order book visibility.

Β 

Outlook

We expect to deliver our normal stronger second half trading performance. This will be supported by the execution of some larger orders in Advanced Technologies, as well as progress in our operational transformation and business restructuring projects, delivering efficiency and cost improvements in the second half of the year. We expect performance for the full year to be in line with expectations on a constant currency basis.

Β 

Based on prevailing exchange rates, the appreciation of sterling is expected to increase the currency headwind on operating profit for the full year by circa Β£1.5-2.0m from previous guidance.2

Β 

Oxford Instruments' results for the half year ending 30 September 2024 will be released on 12 November 2024.

Β 

Β 

Notes:

Β 

1. Adjusted operating profit is before amortisation and impairment of acquired intangible assets, acquisition items, restructuring costs and the mark-to-market revaluation of financial derivatives.

2. Guidance in our 2024 preliminary full-year results announcement in June pointed to a headwind of Β£8.4m to revenue and Β£6.2m to profit for the full year.

Β 

Β 

Enquiries:

Β 

Oxford Instruments plc

Richard Tyson, Chief Executive Officer

Gavin Hill, Chief Financial Officer

Stephen Lamacraft, Head of Investor Relations

Β 

Tel: 01865 393200

investors@oxinst.com

Β 

MHP Group

Katie Hunt/Tim Rowntree/Eleni Menikou/Veronica Farah

Β 

Tel: 07710 117517

oxfordinstruments@mhpgroup.com

Β 

- Ends -

Issued for and on behalf of Oxford Instruments plc

Β 

Notes to Editors Β 

Β 

About Oxford Instruments plc

Oxford Instruments provides academic and commercial organisations worldwide with market-leading scientific technology and expertise across its key market segments: materials analysis, semiconductor, and healthcare & life science.

Innovation is the driving force behind Oxford Instruments' growth and success, supporting its core purpose to accelerate the breakthroughs that create a brighter future for our world. The vigorous search for new ways to make our world greener, healthier and more productive is driving unprecedented levels of R&D investment in new materials and techniques to support productivity and decarbonisation worldwide, creating a significant opportunity for Oxford Instruments to grow.

Oxford Instruments holds a unique position to anticipate global drivers and connect academic researchers with commercial applications engineers, acting as a catalyst that powers real world progress.

Founded in 1959 as the first technology business to be spun out fromβ€―Oxfordβ€―University, Oxford Instruments is now a global company listed on the FTSE250 index of the London Stock Exchange (OXIG).

For more information, visit www.oxinst.comβ€―

Β 

β€―Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTQKPBQABDDPKD
Date   Source Headline
3rd Jun 20248:22 amPRNTotal Voting Rights
31st May 20248:50 amPRNHolding(s) in Company
13th May 20241:15 pmPRNDirector/PDMR Shareholding
1st May 202410:12 amRNSTotal Voting Rights
24th Apr 20244:31 pmPRNHolding(s) in Company
24th Apr 20244:29 pmPRNHolding(s) in Company
16th Apr 20247:00 amRNSTrading Update
11th Apr 202412:54 pmPRNDirector/PDMR Shareholding
2nd Apr 202410:32 amPRNTotal Voting Rights
20th Mar 20244:26 pmPRNDirector/PDMR Shareholding
12th Mar 20248:30 amPRNDirector/PDMR Shareholding
1st Mar 20248:00 amPRNTotal Voting Rights
28th Feb 202411:25 amPRNHolding(s) in Company
12th Feb 20244:15 pmPRNDirector/PDMR Shareholding
1st Feb 20249:10 amPRNTotal Voting Rights
19th Jan 202411:30 amPRNHolding(s) in Company
11th Jan 20244:25 pmPRNDirector/PDMR Shareholding
10th Jan 20247:00 amRNSAcquisition of First Light Imaging SAS
2nd Jan 20241:31 pmPRNBlocklisting - Interim Review
2nd Jan 20241:19 pmPRNTotal Voting Rights
12th Dec 20239:00 amPRNDirector/PDMR Shareholding
1st Dec 20239:00 amPRNTotal Voting Rights
22nd Nov 20232:01 pmPRNAppointment of Independent Non-Executive Director
15th Nov 20234:42 pmPRNDirector/PDMR Shareholding
15th Nov 202312:29 pmPRNDirector/PDMR Shareholding
14th Nov 20237:00 amRNSHalf-Year Results
13th Nov 20231:37 pmPRNDirector/PDMR Shareholding
1st Nov 20239:00 amPRNTotal Voting Rights
17th Oct 20234:13 pmPRNHolding(s) in Company
12th Oct 20234:03 pmPRNDirector/PDMR Shareholding
12th Oct 20237:00 amRNSHalf Year Trading Update
11th Oct 20239:32 amPRNDirector/PDMR Shareholding
2nd Oct 20238:53 amPRNTotal Voting Rights
27th Sep 20234:19 pmPRNDirector/PDMR Shareholding
25th Sep 20234:20 pmPRNDirector/PDMR Shareholding
19th Sep 20231:41 pmPRNAnnual General Meeting 2023 Results
14th Sep 20237:00 amPRNBlock Listing Application
12th Sep 20233:27 pmPRNDirector/PDMR Shareholding
10th Aug 20232:16 pmPRNDirector/PDMR Shareholding
7th Aug 202310:35 amPRNHolding(s) in Company
1st Aug 20232:16 pmRNSTotal Voting Rights
27th Jul 20234:59 pmRNSHolding(s) in Company
27th Jul 20231:51 pmRNSCEO succession update
26th Jul 20235:12 pmRNSDirector/PDMR Shareholding
26th Jul 202311:15 amRNSHolding(s) in Company
25th Jul 202312:44 pmRNSDirector/PDMR Shareholding
20th Jul 202310:23 amPRNPublication of Annual Report and Notice of AGM 2023
10th Jul 20233:26 pmPRNDirector/PDMR Shareholding
6th Jul 20237:00 amRNSAnnual General Meeting: revised date
3rd Jul 20232:37 pmPRNBlocklisting - Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.